Back
T. Rowe Price US Equity Research ETF Vs. Agios Pharmaceuticals Industry Stock Comparison
Buy
64
TSPA
T. Rowe Price US Equity Research ETF
Last Price:
38.14
Seasonality Move:
2.39%
Sell
2
AGIO
Agios Pharmaceuticals
Last Price:
38.94
Seasonality Move:
20.75%
Buy
64
T. Rowe Price US Equity Research ETF (TSPA)
is a Buy
Is T. Rowe Price US Equity Research ETF a Buy, Sell or Hold?
- The current T. Rowe Price US Equity Research ETF [TSPA] share price is $38.13. The Score for TSPA is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- TSPA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
2
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
- The current Agios Pharmaceuticals [AGIO] share price is $38.97. The Score for AGIO is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
- AGIO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
TSPA Stock Price Chart
What is T. Rowe Price US Equity Research ETF's stock price today?
-
The T. Rowe Price US Equity Research ETF share price today is $38.13
The current trend is moderately bullish and TSPA is experiencing slight selling pressure.
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $38.97
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
TSPA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.34 | Buy |
| Relative Strength Index (14 RSI): | 59.64 | Buy |
| Chaikin Money Flow: | -23018 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.34 - 38.18) | Buy |
| Bollinger Bands (100): | (34.5 - 37.38) | Buy |
AGIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.2 | Sell |
| Relative Strength Index (14 RSI): | 28.25 | Sell |
| Chaikin Money Flow: | 740295 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.22 - 61.14) | Sell |
| Bollinger Bands (100): | (41.85 - 53.15) | Sell |
TSPA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.21 | Sell |
| 20-day SMA: | 37.79 | Buy |
| 50-day SMA: | 37.11 | Buy |
| 200-day SMA: | 34.53 | Buy |
| 8-day EMA: | 38.12 | Buy |
| 20-day EMA: | 37.84 | Buy |
| 50-day EMA: | 37.15 | Buy |
| 200-day EMA: | 34.52 | Buy |
AGIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.4 | Sell |
| 20-day SMA: | 53.73 | Sell |
| 50-day SMA: | 49.6 | Sell |
| 200-day SMA: | 41.93 | Sell |
| 8-day EMA: | 46.69 | Sell |
| 20-day EMA: | 51.08 | Sell |
| 50-day EMA: | 50.45 | Sell |
| 200-day EMA: | 42.79 | Sell |
T. Rowe Price US Equity Research ETF Earnings Growth & TSPA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $9.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.46 per share, and a decrease next year of $16.90 per share.
T. Rowe Price US Equity Research ETF Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Agios Pharmaceuticals Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||